PRESS RELEASE: Australani pioneers Psychedelic Therapy in Australia, paving the way for a Transformation in Mental Health Care
[Gold Coast, 1/7/2023]
Australani, a leading healthcare institution in Australia, proudly announces its groundbreaking initiative as the first in Australia to offer psychedelic therapy, to allow use of Psychedelics such as MDMA and Psylocibin by Specialist Doctors. Leveraging the potential of psychedelic substances in mental health treatment, Australani aims to revolutionize the mental health care field, providing new avenues of healing for patients struggling with various mental health conditions.
Australani’s innovative program combines evidence-based therapeutic practices with carefully administered psychedelic substances to unlock profound healing experiences. This pioneering approach offers a ray of hope for individuals suffering from typical pharmaceutical treatment-resistant conditions such as depression, and post-traumatic stress disorder (PTSD).
Dr. Ben Jansen, the Director of Australani, expressed his enthusiasm about Australani’s pioneering stance, stating, “At Australani, we are passionate and dedicated to expanding the boundaries of conventional medicine to better serve our patients. By integrating psychedelic therapy into our family of treatment options, we aim to offer transformative experiences that can facilitate deep healing and long-lasting positive change. We believe this innovative approach has the potential to revolutionize mental healthcare in Australia and beyond.” Dr Jansen further added, “It has been an intensive process to develop our psychedelic therapy program. We are pleased to have secured supply contracts with our pharmaceutical suppliers to provide pharmaceutical MDMA, Psylocibin and Cannabinoid medicines to the Australani public. Treatment under controlled conditions with lawfully pharmaceutically manufactured compounds is far different from illegal “street drugs” and this is something that we very much want to point out to the public for safety reasons. Quality, safety measures and doses are different from recreational use, and in conjunction with therapist guidance, the effects far outweigh those achieved illegally.”
Further supporting the Australani’s vision, Dr. James Heaney, a passionate doctor, and key member of Australani Psychiatric Psychedelic Therapy team, shared his perspective, “Having researched the profound impact of psychedelic therapy has had on some patients and the exciting new scientific data that comes from this field of treatment, I am thrilled to be part of this groundbreaking journey at Australani. This therapeutic modality opens doors to a new realm of possibilities for mental health treatment, offering hope to those who have exhausted other options. We are committed to providing a safe, supportive, and evidence-based environment for our patients throughout their transformative journeys.”
Australani’s dedicated team of medical professionals and therapists have undergone specialised training and adhere to strict safety protocols to ensure the utmost care, precision, and ethical standards in administering psychedelic therapy and compliance with the Therapeutic Goods Administration legislation and guidelines. Australani’s integration of psychedelic therapy aligns with the evolving landscape of mental health care, backed by scientific research and growing evidence of the potential therapeutic benefits of psychedelic substances.
For more information about Australani and its innovative approach to mental healthcare through psychedelic therapy, please visit www.australani.com.au
About Australani:
Australani is a leading healthcare institution based in Australia, prominent for its commitment to excellence and innovation in mental health care. With a multidisciplinary team of experts and cutting-edge treatment modalities, Australani strives to empower individuals to achieve optimal mental well-being and live fulfilling lives.
